Fluconazole Dosing for Fungal Infections
For systemic candidiasis, use a loading dose of 800 mg (12 mg/kg) on day 1, followed by 400 mg (6 mg/kg) daily maintenance dosing. 1, 2, 3
Oropharyngeal Candidiasis
- Loading dose: 200 mg on day 1 2, 4, 3
- Maintenance: 100 mg once daily for 7-14 days 2, 5, 4, 3
- For moderate to severe disease, doses up to 200 mg daily may be used 5, 4
- Continue treatment for at least 2 weeks to decrease relapse likelihood 3
- Important caveat: Relapse rates approach 40% in immunocompromised patients (particularly AIDS patients), who typically require long-term maintenance therapy 6, 7
Esophageal Candidiasis
- Loading dose: 200 mg on day 1 5, 4, 3
- Maintenance: 100 mg once daily 5, 3
- Doses up to 400 mg daily may be used based on clinical response 5, 3
- Duration: Minimum 14-21 days and at least 2 weeks following symptom resolution 2, 5, 3
Systemic Candida Infections (Candidemia, Disseminated Candidiasis)
- Loading dose: 800 mg (12 mg/kg) on day 1 1, 2
- Maintenance: 400 mg (6 mg/kg) daily 1, 2, 5, 3
- Duration: Continue for 2 weeks after first negative blood culture and resolution of symptoms 1, 4
- For candidemia without persistent fungemia or metastatic complications, treat for 2-3 weeks after neutropenia resolution and negative cultures 1
- Critical action: Central venous catheter removal is strongly recommended 2, 4
CNS Candidiasis
- Dose: 400-800 mg (6-12 mg/kg) daily for patients unable to tolerate amphotericin B 1, 2
- Continue until all signs, symptoms, CSF abnormalities, and radiologic findings resolve 1
- Removal of intraventricular devices is recommended 1
Urinary Tract Infections
Symptomatic Cystitis
Pyelonephritis
- Dose: 200-400 mg (3-6 mg/kg) daily for 14 days 1, 2, 5, 4
- If disseminated candidiasis is suspected, treat as candidemia 1
Asymptomatic Cystitis
- Therapy usually not needed 1
- Exception: Treat high-risk surgical patients, neonates, or neutropenic patients as disseminated candidiasis 1
Chronic Disseminated Candidiasis
- Dose: 400 mg (6 mg/kg) daily 2
- Duration: Continue until lesions resolve, typically 3-6 months 1, 2
- Can be used as step-down therapy in stable patients 1
Vaginal Candidiasis
- Single dose: 150 mg as a single oral dose 3, 8
- This provides approximately 75-84% clinical cure rates 6, 8
Cryptococcal Meningitis
- Treatment: 400 mg on day 1, followed by 200 mg once daily 3
- Doses up to 400 mg daily may be used based on response 3
- Duration: 10-12 weeks after CSF becomes culture negative 3
- Maintenance (AIDS patients): 200 mg once daily to prevent relapse 3
Pediatric Dosing Conversion
- 3 mg/kg ≈ 100 mg adult dose 2, 4
- 6 mg/kg ≈ 200 mg adult dose 4
- 12 mg/kg ≈ 400 mg adult dose 1
- Absolute doses exceeding 600 mg/day are not recommended in children 3
Critical Species-Specific Considerations
Fluconazole has NO activity against Candida krusei and variable activity against C. glabrata—confirm susceptibility before use. 2, 5
- C. parapsilosis: Fluconazole is appropriate; if echinocandin used initially, consider switching to fluconazole 1
- C. glabrata: Use echinocandin or amphotericin B initially; only switch to fluconazole if susceptibility confirmed and patient clinically improved 1
- C. krusei: Use echinocandin, amphotericin B, or voriconazole—fluconazole is NOT effective 1
Common Pitfalls to Avoid
- Respiratory secretions: Candida isolated from respiratory tract usually represents colonization, not infection—treatment rarely required 5, 4
- Inadequate treatment duration: Leads to relapse; continue until clinical and laboratory parameters indicate resolution 2
- Resistance development: Particularly problematic in patients with recurrent or chronic infections 4
- Neutropenic patients: Require longer treatment duration (2 weeks after neutropenia resolution) 1